跳至主要内容
临床试验/NCT02502799
NCT02502799终止3 期

Intervention for Teens With ADHD and Substance Use

Florida International University1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
158
试验地点
1
主要终点
Number of Participants With Past 90-day Alcohol Use

研究概览

简要总结

Individuals with ADHD are at markedly high risk for increased substance use and Substance Use Disorder (SUD). Given the strong evidence for the negative trajectory of individuals with co-occurring ADHD and substance use initiation, the goal of this study is to conduct a controlled examination of a brief, early intervention (BEI) for substance modified for adolescents with ADHD. Importantly, this intervention will address individuals who are at risk for problems with substance use, but do not yet meet criteria for severe SUD.

Although brief interventions have been found to be effective in other populations, their efficacy in an ADHD population with emerging risk for substance use problems remains uninvestigated. This study aims to understand why some adolescents with ADHD and elevated risk for SUD respond to (BEI) and others do not. The investigators will test whether situational and individual characteristics predict substance use development and response to treatment. Further, this study will assess which types of additional treatment are most effective for youth who do not respond to the initial BEI. It is hypothesized that rates of adolescent substance use will be lower among adolescents who participate in study treatments.

详细描述

The goal of this study is to evaluate the efficacy of a brief early intervention (BEI) for reducing early alcohol and marijuana use in a group of 300 adolescents (age 12-16) with ADHD. All adolescents will receive the BEI based on the Teen Intervene program with the addition of enhanced decision making skills. Due to the existing support for the intervention and concern for randomizing families with adolescents at risk for worsening substance use outcomes into a control (no treatment) condition for one to two years, no control condition is used in the current design at the first level of intervention. Similarly, due to the time required to see a potential effect of the treatment (6 months post-brief intervention), a wait-list control condition was not considered.

Adolescents will be evaluated for treatment non-response at 6, 9, 12, 15, and 18 months post-treatment. Non-response is defined as non-normative use of alcohol, marijuana, or other drugs during the past 90 days. Tobacco products are excluded from consideration. Adolescents who demonstrate non-response to the initial BEI at any of the follow-up assessments will be randomized to one of the following conditions: 1) Continued monitoring of substance use with no additional treatment 2) Parent training and adolescent cognitive behavioral therapy (PT/ACBT) 3) PT/ACBT plus concurrent stimulant medication (PT/ACBT + MED). Participants who are randomized will be assessed at 6 months post-treatment and again one year later. The difference in days of substance use at the follow-up assessments among the three conditions will inform which type of intervention is best for youth who do not respond to the initial BEI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of ADHD
  • At elevated risk for substance use problems as evidenced by at least one general risk factor (e.g., elevated symptoms of ODD or CD, elevated conflict with parents, low parental monitoring, or academic failure) and at least one substance use specific risk factor (e.g., non-normative use of alcohol or other drugs, use of cigarettes or e-cigarettes, parental substance use problems, family history of substance use problems, peer or sibling substance use).

排除标准

  • Current substance use disorder meeting DSM-IV criteria for the severe qualifier
  • Psychotropic medications for ADHD or any other condition
  • Active medical conditions that could be worsened by stimulants unless approved for participation by the treating physician
  • Diagnosis of bipolar disorder, schizophrenia, and/or other psychotic disorder
  • Diagnosis of autism spectrum disorder (ASD) with a severity level of 2 or 3 or significant intellectual or language impairment

研究组 & 干预措施

Continued Monitoring and Assessment

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. Participants randomized to the continued monitoring and assessment arm will receive no additional intervention. Primary and secondary outcomes will be monitored.

干预措施: Brief Early Intervention (Behavioral)

PT with ACBT

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (CBT).

干预措施: Brief Early Intervention (Behavioral)

PT with ACBT

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (CBT).

干预措施: Parent Training with Adolescent Cognitive Behavioral Therapy (Behavioral)

PT with ACBT and Methylphenidate

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT and Methylphenidate arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (ACBT). Adolescents will also receive methylphenidate.

干预措施: Brief Early Intervention (Behavioral)

PT with ACBT and Methylphenidate

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT and Methylphenidate arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (ACBT). Adolescents will also receive methylphenidate.

干预措施: Parent Training with Adolescent Cognitive Behavioral Therapy (Behavioral)

PT with ACBT and Methylphenidate

Active Comparator

All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT and Methylphenidate arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (ACBT). Adolescents will also receive methylphenidate.

干预措施: Methylphenidate (Drug)

结局指标

主要结局

Number of Participants With Past 90-day Alcohol Use

时间窗: Assessed at 6 months after randomization to treatment

Teen self-report of substance use during the past 90 days

Number of Participants With Evidence of Illicit Substances in Urine Screen

时间窗: Assessed at 6 months after randomization to treatment

Urine analysis indicates presence of illicit substance(s)

次要结局

  • Mean Youth-Report of Parent-adolescent Conflict(Assessed at 6 months after randomization to treatment)
  • Mean Youth Self-Report of Disruptive Behaviors(Assessed at 6 months after randomization to treatment)
  • Mean Youth Self-Report of Likelihood of Future Substance Use(Assessed at 6 months after randomization to treatment)
  • Mean Youth Self-Report of Functional Impairment(Assessed at 6 months after randomization to treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验